See every side of every news story
Published loading...Updated

Guardant Health, Inc. (NASDAQ:GH) Receives Consensus Recommendation of “Buy” from Brokerages

Summary by defenseworld.net
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have earned an average recommendation of “Buy” from the twenty research firms that are covering the firm, Marketbeat reports. Twenty equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $48.40. Several research analysts recently commented on the stock.…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Wednesday, March 26, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.